Isofol Medical (Sweden) Market Value
ISOFOL Stock | SEK 2.99 0.11 3.82% |
Symbol | Isofol |
Isofol Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Isofol Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Isofol Medical.
10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Isofol Medical on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Isofol Medical AB or generate 0.0% return on investment in Isofol Medical over 30 days. Isofol Medical is related to or competes with XSpray Pharma, Oncopeptides, Hansa Biopharma, and Alligator Bioscience. Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and i... More
Isofol Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Isofol Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Isofol Medical AB upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 4.76 | |||
Information Ratio | 0.0133 | |||
Maximum Drawdown | 34.34 | |||
Value At Risk | (9.30) | |||
Potential Upside | 13.49 |
Isofol Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Isofol Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Isofol Medical's standard deviation. In reality, there are many statistical measures that can use Isofol Medical historical prices to predict the future Isofol Medical's volatility.Risk Adjusted Performance | 0.0363 | |||
Jensen Alpha | 0.2857 | |||
Total Risk Alpha | (0.80) | |||
Sortino Ratio | 0.0168 | |||
Treynor Ratio | (0.34) |
Isofol Medical AB Backtested Returns
Isofol Medical appears to be dangerous, given 3 months investment horizon. Isofol Medical AB holds Efficiency (Sharpe) Ratio of 0.0471, which attests that the entity had a 0.0471% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Isofol Medical AB, which you can use to evaluate the volatility of the firm. Please utilize Isofol Medical's Risk Adjusted Performance of 0.0363, downside deviation of 4.76, and Market Risk Adjusted Performance of (0.33) to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Isofol Medical holds a performance score of 3. The company retains a Market Volatility (i.e., Beta) of -0.61, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Isofol Medical are expected to decrease at a much lower rate. During the bear market, Isofol Medical is likely to outperform the market. Please check Isofol Medical's expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Isofol Medical's current trending patterns will revert.
Auto-correlation | 0.33 |
Below average predictability
Isofol Medical AB has below average predictability. Overlapping area represents the amount of predictability between Isofol Medical time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Isofol Medical AB price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Isofol Medical price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.33 | |
Spearman Rank Test | 0.12 | |
Residual Average | 0.0 | |
Price Variance | 0.02 |
Isofol Medical AB lagged returns against current returns
Autocorrelation, which is Isofol Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Isofol Medical's stock expected returns. We can calculate the autocorrelation of Isofol Medical returns to help us make a trade decision. For example, suppose you find that Isofol Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Isofol Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Isofol Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Isofol Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Isofol Medical stock over time.
Current vs Lagged Prices |
Timeline |
Isofol Medical Lagged Returns
When evaluating Isofol Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Isofol Medical stock have on its future price. Isofol Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Isofol Medical autocorrelation shows the relationship between Isofol Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Isofol Medical AB.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Isofol Stock
Isofol Medical financial ratios help investors to determine whether Isofol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Isofol with respect to the benefits of owning Isofol Medical security.